Walleye Capital’s Medifast MED Stock Holding History
Bought
Maintained
Sold
Other funds holding MED
Walleye Capital's MED Position: Q3 2026 in Review
Walleye Capital sold out of Medifast (MED) in Q3 2026, closing a stake of 1,452 shares — an estimated $16.6K sold.
Walleye Capital first reported a position in MED in Q2 2019 and held it in 15 quarters. The position peaked at $2.2M in Q3 2022. 96 funds tracked by Wall St. Rank hold MED as of Q3 2026.
- Walleye Capital reported no remaining Medifast position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 1,452 Medifast shares in Q3 2026, an estimated $16.6K.
- Walleye Capital first reported a position in Medifast in Q2 2019 and held it in 15 quarters.
- Walleye Capital's Medifast position peaked at $2.2M in Q3 2022.
- 96 funds tracked by Wall St. Rank held Medifast as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.